Semaglutide aims to mimic the naturally occurring GLP-1 hormone in the body, extending its potency for therapeutic use in weight management and diabetes
Patients interested in cognitive performance support or those navigating post-concussion recovery have increasingly requested this formula as part of a broader care plan
patients must request pricing through their prescribing provider or telehealth platform
For consistent cellular repletion, a delivery mechanism that bypasses intestinal degradation is essential
Peptides with anti-inflammatory properties can provide relief from chronic pain conditions like arthritis and fibromyalgia
The GLP-1/GIP dual agonist, HRS9531, from Hengrui, reported positive Phase 3 results in weight loss, and is the second (after Innovent) Chinese company to submit marketing authorisation for an obesity asset